{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:43:30Z","timestamp":1790765010541,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SA 292\/13-2"],"award-info":[{"award-number":["SA 292\/13-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHN 1284\/1-2"],"award-info":[{"award-number":["SCHN 1284\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["14-2"],"award-info":[{"award-number":["14-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jmb.2019.05.014","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:11:31Z","timestamp":1557832291000},"page":"3520-3530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Docking on Lipid II\u2014A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides"],"prefix":"10.1016","volume":"431","author":[{"given":"Fabian","family":"Grein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Sahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2019.05.014_bb0005","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jac\/dky019","article-title":"Discovery and development of new antibacterial drugs: learning from experience?","volume":"73","author":"Jackson","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0010","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1016\/j.bbamem.2015.04.014","article-title":"Structural variations of the cell wall precursor lipid II in gram-positive bacteria\u2014impact on binding and efficacy of antimicrobial peptides","volume":"1848","author":"M\u00fcnch","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jmb.2019.05.014_bb0015","first-page":"740","article-title":"Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy","volume":"7","author":"van Bambeke","year":"2006","journal-title":"Curr. Opin. Investig. Drugs (London, England: 2000)"},{"key":"10.1016\/j.jmb.2019.05.014_bb0020","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1021\/ja012273f","article-title":"Cooperative binding interactions of glycopeptide antibiotics","volume":"124","author":"Shiozawa","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2019.05.014_bb0025","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s40265-015-0505-8","article-title":"Lipoglycopeptide antibacterial agents in gram-positive infections: a comparative review","volume":"75","author":"van Bambeke","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jmb.2019.05.014_bb0030","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/AAC.00760-10","article-title":"Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing","volume":"54","author":"Belley","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0035","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jmb.2008.01.031","article-title":"Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus","volume":"377","author":"Kim","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0045","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1021\/acs.biochem.6b01125","article-title":"Desleucyl-oritavancin with a damaged d-Ala\u2013d-Ala binding site inhibits the transpeptidation step of cell-wall biosynthesis in whole cells of Staphylococcus aureus","volume":"56","author":"Kim","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2019.05.014_bb0050","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/AAC.02663-14","article-title":"Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin","volume":"59","author":"M\u00fcnch","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/cr030106n","article-title":"Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity","volume":"105","author":"Walker","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmb.2019.05.014_bb0060","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1021\/ja035217i","article-title":"Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II","volume":"125","author":"Hu","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2019.05.014_bb0065","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1073\/pnas.0904686106","article-title":"A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential lipid II docking interface","volume":"106","author":"Hamburger","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2019.05.014_bb0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/ja039671y","article-title":"Total synthesis and examination of three key analogues of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity","volume":"126","author":"Rew","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2019.05.014_bb0075","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1016\/j.bmcl.2009.09.001","article-title":"Functional and biochemical analysis of a key series of ramoplanin analogues","volume":"19","author":"Fang","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmb.2019.05.014_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1039\/B515328J","article-title":"The mechanism of action of ramoplanin and enduracidin","volume":"2","author":"Fang","year":"2006","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.jmb.2019.05.014_bb0085","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1021\/ja067648h","article-title":"Total synthesis of lysobactin","volume":"129","author":"Guzman-Martinez","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2019.05.014_bb0090","series-title":"Angewandte Chemie","first-page":"2039","article-title":"Structure and total synthesis of lysobactin (katanosin B)","volume":"vol. 46","author":"von Nussbaum","year":"2007"},{"key":"10.1016\/j.jmb.2019.05.014_bb0095","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.45.6.1823-1827.2001","article-title":"Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus","volume":"45","author":"Maki","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2019.05.014_bb0105","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1128\/AAC.01050-16","article-title":"Dual targeting of cell wall precursors by teixobactin leads to cell lysis","volume":"60","author":"Homma","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1039\/C2NP20085F","article-title":"Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature","volume":"30","author":"Arnison","year":"2013","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jmb.2019.05.014_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138920109787048616","article-title":"Lantibiotics: mode of action, biosynthesis and bioengineering","volume":"10","author":"Bierbaum","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/jb.16.5.321-325.1928","article-title":"The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus","volume":"16","author":"Rogers","year":"1928","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrmicro1273","article-title":"Bacteriocins: developing innate immunity for food","volume":"3","author":"Cotter","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0130","first-page":"57","article-title":"Die Wirkung von Nisin auf Clostridium butyricum","volume":"37","author":"Ramseier","year":"1960","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00427192","article-title":"The effect of nisin on murein synthesis","volume":"127","author":"Reisinger","year":"1980","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.27.5.841","article-title":"Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles","volume":"27","author":"Ruhr","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00425076","article-title":"Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin","volume":"149","author":"Sahl","year":"1987","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/AAC.42.1.154","article-title":"The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II","volume":"42","author":"Br\u00f6tz","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2958.1998.01065.x","article-title":"Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics","volume":"30","author":"Br\u00f6tz","year":"1998","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0160","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1126\/science.286.5448.2361","article-title":"Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic","volume":"286","author":"Breukink","year":"1999","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jmb.2019.05.014_bb0165","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1074\/jbc.M006770200","article-title":"Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity","volume":"276","author":"Wiedemann","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2019.05.014_bb0170","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1128\/AAC.50.4.1449-1457.2006","article-title":"Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies","volume":"50","author":"Bonelli","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmb.2019.05.014_bb0175","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/JB.186.10.3259-3261.2004","article-title":"Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study","volume":"186","author":"Wiedemann","year":"2004","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0180","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1021\/bi049476b","article-title":"Assembly and stability of nisin\u2013lipid II pores","volume":"43","author":"Hasper","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2019.05.014_bb0185","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.bbamem.2013.07.014","article-title":"Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity","volume":"1828","author":"Scherer","year":"2013","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jmb.2019.05.014_bb0190","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bpj.2015.01.020","article-title":"The lantibiotic nisin induces lipid II aggregation, causing membrane instability and vesicle budding","volume":"108","author":"Scherer","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.jmb.2019.05.014_bb0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2958.2006.05223.x","article-title":"The mode of action of the lantibiotic lacticin 3147\u2014a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II","volume":"61","author":"Wiedemann","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0200","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1074\/jbc.M211144200","article-title":"NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity","volume":"278","author":"Hsu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2019.05.014_bb0205","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nsmb830","article-title":"The nisin\u2013lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics","volume":"11","author":"Hsu","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0210","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1038\/s41467-018-06314-x","article-title":"High-resolution NMR studies of antibiotics in cellular membranes","volume":"9","author":"Medeiros-Silva","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2019.05.014_bb0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2019.05.014_bb0220","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0225","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1039\/c1np00022e","article-title":"Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation","volume":"28","author":"Wilmes","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jmb.2019.05.014_bb0230","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature04051","article-title":"Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus","volume":"437","author":"Mygind","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2019.05.014_bb0235","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1185723","article-title":"Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II","volume":"328","author":"Schneider","year":"2010","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jmb.2019.05.014_bb0240","doi-asserted-by":"crossref","first-page":"42361","DOI":"10.1074\/jbc.M112.382028","article-title":"Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action","volume":"287","author":"Oeemig","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2019.05.014_bb0245","doi-asserted-by":"crossref","first-page":"34953","DOI":"10.1074\/jbc.M114.599878","article-title":"Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis","volume":"289","author":"Essig","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2019.05.014_bb0250","doi-asserted-by":"crossref","first-page":"29208","DOI":"10.1074\/jbc.M110.143388","article-title":"Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II","volume":"285","author":"Schmitt","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2019.05.014_bb0255","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.febslet.2010.03.004","article-title":"Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II","volume":"584","author":"de Leeuw","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jmb.2019.05.014_bb0260","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/IAI.00688-09","article-title":"Human beta-defensin 3 inhibits cell wall biosynthesis in staphylococci. Human \u03b2-defensin 3 inhibits cell wall biosynthesis in staphylococci","volume":"78","author":"Sass","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jmb.2019.05.014_bb0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.mi.36.100182.001013","article-title":"Colicins and other bacteriocins with established modes of action","volume":"36","author":"Konisky","year":"1982","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0270","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1128\/AEM.00092-08","article-title":"Specific interaction of the unmodified bacteriocin lactococcin 972 with the cell wall precursor lipid II","volume":"74","author":"Mart\u00ednez","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0275","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molstruc.2012.09.076","article-title":"Structure and properties of the metastable bacteriocin Lcn972 from Lactococcus lactis","volume":"1031","author":"Turner","year":"2013","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmb.2019.05.014_bb0280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41564-018-0110-1","article-title":"Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant gram-positive pathogens","volume":"3","author":"Hover","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0285","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/acschembio.9b00157","article-title":"The lasso peptide siamycin-I targets lipid II at the gram-positive cell surface","volume":"14","author":"Tan","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0290","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2958.2009.06815.x","article-title":"Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed?","volume":"73","author":"Henrichfreise","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijmm.2016.12.001","article-title":"The cell wall precursor lipid II acts as a molecular signal for the Ser\/Thr kinase PknB of Staphylococcus aureus","volume":"307","author":"Hardt","year":"2017","journal-title":"Int. J, Med. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0300","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2958.2004.04420.x","article-title":"Recruitment of penicillin-binding protein PBP2 to the division site of Staphylococcus aureus is dependent on its transpeptidation substrates","volume":"55","author":"Pinho","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0305","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1111\/1462-2920.12206","article-title":"The localization of key Bacillus subtilis penicillin binding proteins during cell growth is determined by substrate availability","volume":"15","author":"Lages","year":"2013","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nchembio.1689","article-title":"Lipid-linked cell wall precursors regulate membrane association of bacterial actin MreB","volume":"11","author":"Schirner","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0315","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/jacs.5b11807","article-title":"The mechanism of action of lysobactin","volume":"138","author":"Lee","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2019.05.014_bb0320","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrd2004","article-title":"Lipid II as a target for antibiotics","volume":"5","author":"Breukink","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmb.2019.05.014_bb0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jmb.2019.05.014_bb0330","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41426-018-0205-z","article-title":"Emergence of a dalbavancin induced glycopeptide\/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis","volume":"7","author":"Kussmann","year":"2018","journal-title":"Emerging microbes & infections"},{"key":"10.1016\/j.jmb.2019.05.014_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002509","article-title":"Identification and in vitro analysis of the GatD\/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus","volume":"8","author":"M\u00fcnch","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jmb.2019.05.014_bb0340","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1089\/mdr.2014.0042","article-title":"Contribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of Staphylococcus aureus","volume":"20","author":"Figueiredo","year":"2014","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.jmb.2019.05.014_bb0345","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0966-842X(96)10063-9","article-title":"Glycopeptide resistance in enterococci","volume":"4","author":"Arthur","year":"1996","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jmb.2019.05.014_bb0350","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/bi00222a002","article-title":"Identification of vancomycin resistance protein VanA as a d-alanine:d-alanine ligase of altered substrate specificity","volume":"30","author":"Bugg","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2019.05.014_bb0355","first-page":"157","article-title":"Lipid II and other bactoprenol-bound cell wall precursors as drug targets","volume":"11","author":"Schneider","year":"2010","journal-title":"Curr. Opin. Investig. Drugs (London, England: 2000)"},{"key":"10.1016\/j.jmb.2019.05.014_bb0360","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/271223a0","article-title":"Structure of vancomycin and its complex with acetyl-d-alanyl\u2013d-alanine","volume":"271","author":"Sheldrick","year":"1978","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jmb.2019.05.014_bb5000","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41467-019-09223-9","article-title":"LipidII interaction with specific residues of Mycobacterium tuberculosis PknB extracytoplasmic domain governs its optimal activation","volume":"10","author":"Kaur","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283619302815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283619302815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:17:20Z","timestamp":1762669040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283619302815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":73,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0022283619302815"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2019.05.014","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docking on Lipid II\u2014A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2019.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}